Profound Medical Corp. (PROF) Stock Overview
Explore Profound Medical Corp.’s financial performance, market position, analyst ratings, and future outlook.
Profound Medical Corp. (PROF)
Key Financials
Key Financials
Market Cap
196.7M
P/E Ratio
-5.22
EPS (TTM)
$-1.24
ROE
-0.70%
PROF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Profound Medical Corp. (PROF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 47.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.59.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.22 and a market capitalization of 196.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.